Age-related differences in susceptibility to cisplatin-induced renal toxicity
Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model,...
Gespeichert in:
Veröffentlicht in: | Journal of applied toxicology 2010-03, Vol.30 (2), p.172-182 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 182 |
---|---|
container_issue | 2 |
container_start_page | 172 |
container_title | Journal of applied toxicology |
container_volume | 30 |
creator | Espandiari, P. Rosenzweig, B. Zhang, J. Zhou, Y. Schnackenberg, L. Vaidya, V. S. Goering, P. L. Brown, R. P. Bonventre, J. V. Mahjoob, K. Holland, R. D. Beger, R. D. Thompson, K. Hanig, J. Sadrieh, N. |
description | Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague–Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg−1 i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were ≥ 25 days old. Several serum, urinary and ‘omic’ injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age‐related Cis‐induced nephrotoxicity was different than our previous study with gentamicin: 80 > 40 > 10 > 25 day‐old vs 10 ≥ 80 > 40 > 25‐day‐old rats, respectively. The increased levels of kidney injury molecule‐1 (Kim‐1: urinary protein/tissue mRNA) provided evidence of early Cis‐induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim‐1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi‐age rat model can be used to demonstrate different age‐related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers. Published in 2009 by John Wiley & Sons, Ltd.
Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). |
doi_str_mv | 10.1002/jat.1484 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2829343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>883022783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6074-25390729e7a7383f5d2bda9015edf5720cbe047c4cc2aa984b86002319cf56f13</originalsourceid><addsrcrecordid>eNqNkUtv1DAUhS0EotOCxC9A2SC6SbGv49cGaTSCFlQeiyJQN5bj2MXFkwx2Ap1_j0cTDbBAYuXF-XzOvfcg9ITgM4IxvLg14xlpZHMPLQhWqibA6X20wMBx3VDx5Qgd53yLcdFAPkRHREmqirpA75Y3rk4umtF1VRe8d8n11uUq9FWesnWbMbQhhnFbjUNlQ94UNPR16LvJli-FNrFId8EW5hF64E3M7vH8nqBPr19drS7qyw_nb1bLy9pyLJoaWEkXoJwwgkrqWQdtZxQmzHWeCcC2dbgRtrEWjFGyaSUva1KirGfcE3qCXu59N1O7dp11_ZhM1JsU1iZt9WCC_lvpw1d9M_zQIEHRhhaD57NBGr5PLo96HcqyMZreDVPWUlIMIOR_kFwxyYBDIU_3pE1Dzsn5wzwE611NutSkdzUV9Omf8_8G514K8GwGTLYm-mT6cvsDB9CAYHxnVO-5nyG67T8D9dvl1Rw88yGP7u7Am_RNc0EF05_fn-uL1TX-eA1cM_oL_pC40w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>869585262</pqid></control><display><type>article</type><title>Age-related differences in susceptibility to cisplatin-induced renal toxicity</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Espandiari, P. ; Rosenzweig, B. ; Zhang, J. ; Zhou, Y. ; Schnackenberg, L. ; Vaidya, V. S. ; Goering, P. L. ; Brown, R. P. ; Bonventre, J. V. ; Mahjoob, K. ; Holland, R. D. ; Beger, R. D. ; Thompson, K. ; Hanig, J. ; Sadrieh, N.</creator><creatorcontrib>Espandiari, P. ; Rosenzweig, B. ; Zhang, J. ; Zhou, Y. ; Schnackenberg, L. ; Vaidya, V. S. ; Goering, P. L. ; Brown, R. P. ; Bonventre, J. V. ; Mahjoob, K. ; Holland, R. D. ; Beger, R. D. ; Thompson, K. ; Hanig, J. ; Sadrieh, N.</creatorcontrib><description>Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague–Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg−1 i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were ≥ 25 days old. Several serum, urinary and ‘omic’ injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age‐related Cis‐induced nephrotoxicity was different than our previous study with gentamicin: 80 > 40 > 10 > 25 day‐old vs 10 ≥ 80 > 40 > 25‐day‐old rats, respectively. The increased levels of kidney injury molecule‐1 (Kim‐1: urinary protein/tissue mRNA) provided evidence of early Cis‐induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim‐1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi‐age rat model can be used to demonstrate different age‐related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers. Published in 2009 by John Wiley & Sons, Ltd.
Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis).</description><identifier>ISSN: 0260-437X</identifier><identifier>ISSN: 1099-1263</identifier><identifier>EISSN: 1099-1263</identifier><identifier>DOI: 10.1002/jat.1484</identifier><identifier>PMID: 19839026</identifier><identifier>CODEN: JJATDK</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Age Factors ; age-related nephrotoxicity ; Aging - physiology ; Animals ; Biological and medical sciences ; biomarkers ; Biomarkers - metabolism ; Biomarkers - urine ; Child ; cisplatin ; Cisplatin - toxicity ; Disease Susceptibility - metabolism ; Disease Susceptibility - pathology ; Drug toxicity and drugs side effects treatment ; Gentamicins - toxicity ; Humans ; Kidney - metabolism ; Kidney - pathology ; Kidney Diseases - chemically induced ; Kidney Diseases - pathology ; Kidney Diseases - urine ; Kim-1 ; Medical sciences ; metabonomics ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Models, Animal ; Pediatrics ; Pharmacology. Drug treatments ; Rats ; Rats, Sprague-Dawley ; Sensitivity and Specificity</subject><ispartof>Journal of applied toxicology, 2010-03, Vol.30 (2), p.172-182</ispartof><rights>Copyright © 2009 John Wiley & Sons, Ltd.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6074-25390729e7a7383f5d2bda9015edf5720cbe047c4cc2aa984b86002319cf56f13</citedby><cites>FETCH-LOGICAL-c6074-25390729e7a7383f5d2bda9015edf5720cbe047c4cc2aa984b86002319cf56f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjat.1484$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjat.1484$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22427564$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19839026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Espandiari, P.</creatorcontrib><creatorcontrib>Rosenzweig, B.</creatorcontrib><creatorcontrib>Zhang, J.</creatorcontrib><creatorcontrib>Zhou, Y.</creatorcontrib><creatorcontrib>Schnackenberg, L.</creatorcontrib><creatorcontrib>Vaidya, V. S.</creatorcontrib><creatorcontrib>Goering, P. L.</creatorcontrib><creatorcontrib>Brown, R. P.</creatorcontrib><creatorcontrib>Bonventre, J. V.</creatorcontrib><creatorcontrib>Mahjoob, K.</creatorcontrib><creatorcontrib>Holland, R. D.</creatorcontrib><creatorcontrib>Beger, R. D.</creatorcontrib><creatorcontrib>Thompson, K.</creatorcontrib><creatorcontrib>Hanig, J.</creatorcontrib><creatorcontrib>Sadrieh, N.</creatorcontrib><title>Age-related differences in susceptibility to cisplatin-induced renal toxicity</title><title>Journal of applied toxicology</title><addtitle>J. Appl. Toxicol</addtitle><description>Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague–Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg−1 i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were ≥ 25 days old. Several serum, urinary and ‘omic’ injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age‐related Cis‐induced nephrotoxicity was different than our previous study with gentamicin: 80 > 40 > 10 > 25 day‐old vs 10 ≥ 80 > 40 > 25‐day‐old rats, respectively. The increased levels of kidney injury molecule‐1 (Kim‐1: urinary protein/tissue mRNA) provided evidence of early Cis‐induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim‐1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi‐age rat model can be used to demonstrate different age‐related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers. Published in 2009 by John Wiley & Sons, Ltd.
Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis).</description><subject>Age Factors</subject><subject>age-related nephrotoxicity</subject><subject>Aging - physiology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>biomarkers</subject><subject>Biomarkers - metabolism</subject><subject>Biomarkers - urine</subject><subject>Child</subject><subject>cisplatin</subject><subject>Cisplatin - toxicity</subject><subject>Disease Susceptibility - metabolism</subject><subject>Disease Susceptibility - pathology</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Gentamicins - toxicity</subject><subject>Humans</subject><subject>Kidney - metabolism</subject><subject>Kidney - pathology</subject><subject>Kidney Diseases - chemically induced</subject><subject>Kidney Diseases - pathology</subject><subject>Kidney Diseases - urine</subject><subject>Kim-1</subject><subject>Medical sciences</subject><subject>metabonomics</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Models, Animal</subject><subject>Pediatrics</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sensitivity and Specificity</subject><issn>0260-437X</issn><issn>1099-1263</issn><issn>1099-1263</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1DAUhS0EotOCxC9A2SC6SbGv49cGaTSCFlQeiyJQN5bj2MXFkwx2Ap1_j0cTDbBAYuXF-XzOvfcg9ITgM4IxvLg14xlpZHMPLQhWqibA6X20wMBx3VDx5Qgd53yLcdFAPkRHREmqirpA75Y3rk4umtF1VRe8d8n11uUq9FWesnWbMbQhhnFbjUNlQ94UNPR16LvJli-FNrFId8EW5hF64E3M7vH8nqBPr19drS7qyw_nb1bLy9pyLJoaWEkXoJwwgkrqWQdtZxQmzHWeCcC2dbgRtrEWjFGyaSUva1KirGfcE3qCXu59N1O7dp11_ZhM1JsU1iZt9WCC_lvpw1d9M_zQIEHRhhaD57NBGr5PLo96HcqyMZreDVPWUlIMIOR_kFwxyYBDIU_3pE1Dzsn5wzwE611NutSkdzUV9Omf8_8G514K8GwGTLYm-mT6cvsDB9CAYHxnVO-5nyG67T8D9dvl1Rw88yGP7u7Am_RNc0EF05_fn-uL1TX-eA1cM_oL_pC40w</recordid><startdate>201003</startdate><enddate>201003</enddate><creator>Espandiari, P.</creator><creator>Rosenzweig, B.</creator><creator>Zhang, J.</creator><creator>Zhou, Y.</creator><creator>Schnackenberg, L.</creator><creator>Vaidya, V. S.</creator><creator>Goering, P. L.</creator><creator>Brown, R. P.</creator><creator>Bonventre, J. V.</creator><creator>Mahjoob, K.</creator><creator>Holland, R. D.</creator><creator>Beger, R. D.</creator><creator>Thompson, K.</creator><creator>Hanig, J.</creator><creator>Sadrieh, N.</creator><general>John Wiley & Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7U7</scope><scope>C1K</scope><scope>SOI</scope><scope>5PM</scope></search><sort><creationdate>201003</creationdate><title>Age-related differences in susceptibility to cisplatin-induced renal toxicity</title><author>Espandiari, P. ; Rosenzweig, B. ; Zhang, J. ; Zhou, Y. ; Schnackenberg, L. ; Vaidya, V. S. ; Goering, P. L. ; Brown, R. P. ; Bonventre, J. V. ; Mahjoob, K. ; Holland, R. D. ; Beger, R. D. ; Thompson, K. ; Hanig, J. ; Sadrieh, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6074-25390729e7a7383f5d2bda9015edf5720cbe047c4cc2aa984b86002319cf56f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Age Factors</topic><topic>age-related nephrotoxicity</topic><topic>Aging - physiology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>biomarkers</topic><topic>Biomarkers - metabolism</topic><topic>Biomarkers - urine</topic><topic>Child</topic><topic>cisplatin</topic><topic>Cisplatin - toxicity</topic><topic>Disease Susceptibility - metabolism</topic><topic>Disease Susceptibility - pathology</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Gentamicins - toxicity</topic><topic>Humans</topic><topic>Kidney - metabolism</topic><topic>Kidney - pathology</topic><topic>Kidney Diseases - chemically induced</topic><topic>Kidney Diseases - pathology</topic><topic>Kidney Diseases - urine</topic><topic>Kim-1</topic><topic>Medical sciences</topic><topic>metabonomics</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Models, Animal</topic><topic>Pediatrics</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Espandiari, P.</creatorcontrib><creatorcontrib>Rosenzweig, B.</creatorcontrib><creatorcontrib>Zhang, J.</creatorcontrib><creatorcontrib>Zhou, Y.</creatorcontrib><creatorcontrib>Schnackenberg, L.</creatorcontrib><creatorcontrib>Vaidya, V. S.</creatorcontrib><creatorcontrib>Goering, P. L.</creatorcontrib><creatorcontrib>Brown, R. P.</creatorcontrib><creatorcontrib>Bonventre, J. V.</creatorcontrib><creatorcontrib>Mahjoob, K.</creatorcontrib><creatorcontrib>Holland, R. D.</creatorcontrib><creatorcontrib>Beger, R. D.</creatorcontrib><creatorcontrib>Thompson, K.</creatorcontrib><creatorcontrib>Hanig, J.</creatorcontrib><creatorcontrib>Sadrieh, N.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Environment Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of applied toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Espandiari, P.</au><au>Rosenzweig, B.</au><au>Zhang, J.</au><au>Zhou, Y.</au><au>Schnackenberg, L.</au><au>Vaidya, V. S.</au><au>Goering, P. L.</au><au>Brown, R. P.</au><au>Bonventre, J. V.</au><au>Mahjoob, K.</au><au>Holland, R. D.</au><au>Beger, R. D.</au><au>Thompson, K.</au><au>Hanig, J.</au><au>Sadrieh, N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age-related differences in susceptibility to cisplatin-induced renal toxicity</atitle><jtitle>Journal of applied toxicology</jtitle><addtitle>J. Appl. Toxicol</addtitle><date>2010-03</date><risdate>2010</risdate><volume>30</volume><issue>2</issue><spage>172</spage><epage>182</epage><pages>172-182</pages><issn>0260-437X</issn><issn>1099-1263</issn><eissn>1099-1263</eissn><coden>JJATDK</coden><abstract>Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis). Sprague–Dawley rats (10, 25, 40 and 80 days old) were injected with a single dose of Cis (0, 1, 3 or 6 mg kg−1 i.p.). Urine samples were collected prior and up to 72 h after treatment in animals that were ≥ 25 days old. Several serum, urinary and ‘omic’ injury biomarkers as well as renal histopathology lesions were evaluated. Statistically significant changes were noted with different injury biomarkers in different age groups. The order of age‐related Cis‐induced nephrotoxicity was different than our previous study with gentamicin: 80 > 40 > 10 > 25 day‐old vs 10 ≥ 80 > 40 > 25‐day‐old rats, respectively. The increased levels of kidney injury molecule‐1 (Kim‐1: urinary protein/tissue mRNA) provided evidence of early Cis‐induced nephrotoxicity in the most sensitive age group (80 days old). Levels of Kim‐1 tissue mRNA and urinary protein were significantly correlated to each other and to the severity of renal histopathology lesions. These data indicate that the multi‐age rat model can be used to demonstrate different age‐related sensitivities to renal injury using mechanistically distinct nephrotoxicants, which is reflected in measurements of a variety of metabolite, gene transcript and protein biomarkers. Published in 2009 by John Wiley & Sons, Ltd.
Limited experimental models exist to assess drug toxicity in pediatric populations. We recently reported how a multi‐age rat model could be used for pre‐clinical studies of comparative drug toxicity in pediatric populations. The objective of this study was to expand the utility of this animal model, which previously demonstrated an age‐dependent sensitivity to the classic nephrotoxic compound, gentamicin, to another nephrotoxicant, namely cisplatin (Cis).</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>19839026</pmid><doi>10.1002/jat.1484</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0260-437X |
ispartof | Journal of applied toxicology, 2010-03, Vol.30 (2), p.172-182 |
issn | 0260-437X 1099-1263 1099-1263 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2829343 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Age Factors age-related nephrotoxicity Aging - physiology Animals Biological and medical sciences biomarkers Biomarkers - metabolism Biomarkers - urine Child cisplatin Cisplatin - toxicity Disease Susceptibility - metabolism Disease Susceptibility - pathology Drug toxicity and drugs side effects treatment Gentamicins - toxicity Humans Kidney - metabolism Kidney - pathology Kidney Diseases - chemically induced Kidney Diseases - pathology Kidney Diseases - urine Kim-1 Medical sciences metabonomics Miscellaneous (drug allergy, mutagens, teratogens...) Models, Animal Pediatrics Pharmacology. Drug treatments Rats Rats, Sprague-Dawley Sensitivity and Specificity |
title | Age-related differences in susceptibility to cisplatin-induced renal toxicity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T23%3A34%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age-related%20differences%20in%20susceptibility%20to%20cisplatin-induced%20renal%20toxicity&rft.jtitle=Journal%20of%20applied%20toxicology&rft.au=Espandiari,%20P.&rft.date=2010-03&rft.volume=30&rft.issue=2&rft.spage=172&rft.epage=182&rft.pages=172-182&rft.issn=0260-437X&rft.eissn=1099-1263&rft.coden=JJATDK&rft_id=info:doi/10.1002/jat.1484&rft_dat=%3Cproquest_pubme%3E883022783%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=869585262&rft_id=info:pmid/19839026&rfr_iscdi=true |